Current research into drug treatments for CLL - specifically ibrutinib, idelalisib and venetoclax
Importance of prognostic factors in the treatment of CLL and how to assess them
Inherited and acquired genetic factors involved in the development of CLL
John Gribben et al.
The side-effects profile of novel drugs in chronic lymphocytic leukemia
Overview of the RESONATE-2 clinical trial of ibrutinib as front-line therapy